Market Research Report
Europe Digital Genome Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||991379|
|Published||Content info||143 Pages
Delivery time: 2-3 business days
|Europe Digital Genome Market Forecast 2021-2028|
|Published: March 1, 2021||Content info: 143 Pages||
The Europe digital genome market is anticipated to record a CAGR of 9.16%, across the forecast years of 2021 to 2028. The launch of innovative technologies for genome projects, the increasing number of genome researches conducted, and the rising government and private funding for genome sequencing, essentially fuel the region's market growth.
The Europe digital genome market growth is determined by analyzing Italy, France, the United Kingdom, Belgium, Russia, Poland, Germany, and the rest of Europe. Germany is regarded as one of the most extensive hubs for biotechnology across Europe, and globally. The prominence is attributed to the widespread prevalence of leading biotechnology firms, the massive funding for conducting research and development, and high-tech research labs. The country also headquarters more biotechnology companies than other countries in Europe. Moreover, the high-quality research in Germany results in lucrative opportunities, and therefore, a well-established digital genome market.
On the other hand, the augmenting genomic research for agriculture is projected to favor the digital genome market growth in Italy. The Genomics Research Centre of Fiorenzuola d'Arda is part of the Consiglio per la ricerca in agricoltura e l'analisi dell'economia agraria (CREA). It operates under the authority and supervision of Italy's Ministry of Agriculture, and possesses expertise in fields like bioinformatics, proteomics, and plant genomics. The center's research endeavors concentrate on the structure, comprehension, and function of genes and their products, increasing food safety, security, quality, and genetically improvising crop species. Hence, these factors are set to propel the market growth in Europe, across the forecast period.
Some of the eminent companies operating in the market are, Biomerieux SA, Thermo Fisher Scientific Inc, Qiagen, F. Hoffman-La Roche Ltd, etc.